2-Amino-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylic acid methyl ester, 96.0%, 10g

7-METHOXY-1,2,3,4-TETRAHYDRONAPHTHALEN-1-AMINE, 95.0%, 1g

Benzene, 4-bromo-1-ethyl-2-methoxy-, 95%, 1g

1-(Tert-butyl) 7-methyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1,7-dicarboxylate, 96%, 250mg

(S,Z)-(2-(5-((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethyl)diphenylphosphine oxide, 96%, 250mg

Sal sódica del ácido 8-hidroxiquinolina-β-D-glucurónico, 250 mg, >=98 %

D-luciferina, mínimo 99 %, para bioquímica, 25 mg, envase de vidrio

(6-Bromopyridin-2-yl)methanol>98.0%(GC)1g

Báscula compacta serie CX, 0,1 g, 620 g, CX621

Tert-butyl 4-(6-((8-cyclopentyl-5-methyl-7-oxo-6-(1-propoxyvinyl)-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate, 98%, 100mg

2-Bromo-5-nitrobenzenesulfonyl chloride, 98+%, 1g

Artemisinin>97.0%(HPLC)5g

3'-Hydroxy-4'-methoxyacetophenone, 98.0%, 1g